Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Multiple Sclerosis: HELP
Richard A. Rudick
Based on 65 articles published since 2008
||||
Expertise Level
The expertise of Richard A. Rudick ranks in the
  • Top 0.078%
  • ... of 53,601 published authors worldwide on Multiple Sclerosis
  • ... from 2008 through 2018
  • ... based on contributions to 65 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Rudick, Richard   ·   Rudick, R A   ·   Rudick, Richard A
Work Locations
Details
Most likely:    Miscellaneous institutions in Boston      
2017
  • Department of Neurology, New York University School of Medicine, New York, NY, USA. · National Hospital for Neurology and Neurosurgery, London, UK. · Department of Neurology, University at Buffalo, Buffalo, NY, USA. · Biogen, Cambridge, MA, USA. · National Multiple Sclerosis Society, New York, NY, USA. · Critical Path Institute, Tucson, AZ, USA. · Multiple Sclerosis Outcome Assessments Consortium (MSOAC), Critical Path Institute, Tucson, AZ, USA. · Pubmed 28206829
  • Department of Physical Therapy, University of Alabama at Birmingham, Birmingham, AL, USA. · Mellen Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA. · Department of Neurology, University at Buffalo, Buffalo, NY, USA. · Biogen, Cambridge, MA, USA. · National Multiple Sclerosis Society, New York, NY, USA. · Critical Path Institute, Tucson, AZ, USA. · Multiple Sclerosis Outcome Assessments Consortium (MSOAC), Critical Path Institute, Tucson, AZ, USA. · Pubmed 28206828
  • Department of Neurology and Buffalo General Medical Center, University at Buffalo, Buffalo, NY, USA. · Kessler Foundation, West Orange, NJ, USA; Rutgers New Jersey Medical School, Newark, NJ, USA. · Biogen, Cambridge, MA, USA. · National Multiple Sclerosis Society, New York, NY, USA. · Critical Path Institute, Tucson, AZ, USA. · Multiple Sclerosis Outcome Assessments Consortium (MSOAC), Critical Path Institute, Tucson, AZ, USA. · Pubmed 28206827
  • Rehabilitation Research Center (REVAL), Biomedical Research Institute (BIOMED), Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium. · Neuroscience Clinical Development, San Francisco, CA, USA. · Department of Neurology, University at Buffalo, Buffalo, NY, USA. · Biogen, Cambridge, MA, USA. · National Multiple Sclerosis Society, New York, NY, USA. · Critical Path Institute, Tucson, AZ, USA. · Multiple Sclerosis Outcome Assessments Consortium (MSOAC), Critical Path Institute, Tucson, AZ, USA. · Pubmed 28206826
  • Schey Center for Cognitive Neuroimaging, Lou Ruvo Center for Brain Health, Neurological Institute, Cleveland Clinic Foundation, Cleveland, OH, USA. · Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA. · Bayer Healthcare LLC, Whippany, NJ, USA. · McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC, Canada. · Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Cleveland, OH, USA. · Biogen, Cambridge, MA, USA. · Pubmed 28080262
2016
  • Biogen Inc., Cambridge, USA Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, USA · Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, USA. · Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, USA. · Biogen Inc., Cambridge, USA. · Pubmed 26238463
2015
  • Mellen Center for Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland, Ohio. · Biogen, Boston, Massachusetts. · Pubmed 26053218
Probable:    Miscellaneous cities in USA      
2015
  • Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, USA · Mellen Center for Multiple Sclerosis Treatment and Research/Neurological Institute Center for Outcomes Research and Evaluation/ Department of Quantitative Health Sciences, Cleveland Clinic, USA. · Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, USA. · Biogen Idec./Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, USA. · Pubmed 25112816
2014
2009
  • Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, USA. · Pubmed 19812410
Probable:    Cleveland Clinic   Contact    
2014
  • From the Department of Neurology (P.O.), St. Michael's Hospital, Toronto, Canada · Department of Neurology (A.G.), University of Rochester, NY · Departments of Neurology and Biomedicine (L.K.), University Hospital Basel, Switzerland · Corinne Goldsmith Dickinson Center for MS at The Icahn School of Medicine at Mount Sinai (F.L.), New York, NY · Department of Neurology (C.P.), VU Medical Centre, Amsterdam, the Netherlands · Mellen Center for Multiple Sclerosis Treatment and Research (R.A.R.), Cleveland Clinic Foundation, OH · Infusion Communications (K.H.), Haddam, CT · Departments of Safety and Benefit-Risk Management (L.M.C.) and Biostatistics (F.F.), Biogen Idec Inc., Cambridge · and Sarepta Therapeutics (P.D.), Cambridge, MA · P.D., a former employee of Biogen Idec Inc., was at the company during study conduct. · Pubmed 24898925
  • From the Corinne Goldsmith Dickenson Center for Multiple Sclerosis (F.D.L., A.E.M.), Icahn School of Medicine at Mount Sinai, New York, NY · Scientific and Clinical Review Associates, LLC (S.C.R.), Salisbury, CT · The Mellen Center for MS Treatment and Research (J.A.C., R.J.F., R.A.R.), Cleveland Clinic, OH · the Department of Biostatistics (G.R.C.), University of Alabama at Birmingham · the Danish Multiple Sclerosis Center (P.S.S.), Department of Neurology, Copenhagen University Hospital Rigshospitalet, Denmark · University College London Institute of Neurology (A.J.T.), UK · the Department of Neurology (J.S.W., J.A.L.), University of Texas Health Sciences Center, Houston · the Department of Neurology (L.J.B.), New York University Langone Medical Center, New York · the Division of Neurology (B. Banwell), The Children's Hospital of Philadelphia, PA · the Departments of Radiology and Nuclear Medicine (F.B.) and Neurology (C.H.P.), VU Medical Center, Amsterdam, the Netherlands · Research Programs Department (B. Bebo), National Multiple Sclerosis Society, New York, NY · the Department of Neurology (P.A.C.), The Johns Hopkins Hospital, Baltimore, MD · Fédération de Neurologie (M.C.), CHU Hôpital Purpan, Toulouse, France · the Department of Neurology (G.C.), Scientific Institute San Raffaele, University Vita-Salute San Raffaele, Milan, Italy · University of Ottawa and the Ottawa Hospital Research Institute (M.S.F.), Canada · the Department of Neurology (A.D.G.), University of Rochester Medical Center, NY · the Departments of Neurology, Radiology and Neuroscience (M.I.), Mount Sinai School of Medicine, New York, NY · the Department of Neurology (L.K.), University Hospital, Basel, Switzerland · the Department of Neurology (B.C.K.), Heinrich-Heine-University, Düsseldorf, Germany · the Department of Neurology (C.L.), Salpêtrière Hospital, UPMC, Paris, France · the Department of Neurology-Neuroimmunology (X.M.), Cemcat, Hospital Universitari Vall d'Hebron, Barcelona, Spain · the Division of · Pubmed 24871874
2013
  • Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. · Pubmed 23128399
2012
  • Mellen Center for Multiple Sclerosis Treatment and Research, Department of Neurology, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA. · Pubmed 22494954
2011
  • Mellen Center for Multiple Sclerosis Treatment and Research, Department of Neurology, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA. · Pubmed 21396360
  • Mellen Center for Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, United States of America. · Pubmed 21602934
  • Mellen Center for Multiple Sclerosis, Cleveland Clinic, 9500 Euclid Ave., U10, Cleveland, OH 44195, USA. · Pubmed 22123928
  • Mellen Center for Treatment and Research (Neurological Institute), The Cleveland Clinic Foundation, Cleveland, OH 44195, USA. · Pubmed 20965959
2010
  • Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, USA. · Pubmed 20625068
2009
  • Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, USA. · Pubmed 19446274
  • Mellen Center for Treatment and Research in Multiple Sclerosis, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA. · Pubmed 19506220
  • Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH 44106, USA. · Pubmed 19667023
  • Mellen Center for MS Treatment and Research U10, Neurologic Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA. · Pubmed 19100997
2008
  • Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. · Pubmed 18788835
  • Mellen Center for Multiple Sclerosis Treatment and Research, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA. · Pubmed 18774923
2015
  • 1Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA. · Pubmed 25271798
2013
  • Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research, 9500 Euclid Ave, Cleveland, OH 44195-5244, USA. · Pubmed 23599930
  • Neurological Institute, Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, OH, USA. · Pubmed 23378325
2012
  • Mellen Center, Department of Neurology, Cleveland Clinic, Cleveland, OH, USA. · Pubmed 23040960
2011
  • Department of Neurology, Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA. · Pubmed 21455068
  • Department of Molecular Genetics, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA. · Pubmed 22106296
  • Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, U-10 9500 Euclid Avenue, Cleveland, OH 44118, USA. · Pubmed 21300736
  • Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, Ohio 44195, USA. · Pubmed 21214498
2010
  • Mellen Center for Multiple Sclerosis Treatment and Research, U-10, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA. · Pubmed 20421570
  • Department of Neurology, Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH 44195, USA. · Pubmed 20167591
  • Mellen Center for Treatment and Research in Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA. · Pubmed 20064056
2009
  • Neuroinflammation Research Center, Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA. · Pubmed 20074275
2008
  • Department of Neurology, Mellen Center, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. · Pubmed 18701575
  • Department of Biomedical Engineering, Cleveland Clinic Foundation, Cleveland, OH 44195, USA. · Pubmed 18661561
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 65 total) written by Richard A. Rudick about Multiple Sclerosis:

  • Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis. 2017
  • Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis. 2017
  • Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis. 2017
  • The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis. 2017
  • Processing speed test: Validation of a self-administered, iPad 2017
  • Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing-remitting multiple sclerosis: A retrospective analysis. 2016
  • The Future of Research in Multiple Sclerosis. 2015
  • Experience with fingolimod in clinical practice. 2015
  • Factors associated with clinically significant increased walking time in multiple sclerosis: results of a survival analysis of short-term follow-up data from a clinical database. 2015
  • Simple MRI metrics contribute to optimal care of the patient with multiple sclerosis. 2014
Show List of Full Article Records
Google Searches

Learn more about Richard A. Rudick using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous institutions in Boston
Miscellaneous cities in USA
Cleveland Clinic
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous institutions in Boston
2017
  • Department of Neurology, New York University School of Medicine, New York, NY, USA. · National Hospital for Neurology and Neurosurgery, London, UK. · Department of Neurology, University at Buffalo, Buffalo, NY, USA. · Biogen, Cambridge, MA, USA. · National Multiple Sclerosis Society, New York, NY, USA. · Critical Path Institute, Tucson, AZ, USA. · Multiple Sclerosis Outcome Assessments Consortium (MSOAC), Critical Path Institute, Tucson, AZ, USA. · Pubmed 28206829
  • Department of Physical Therapy, University of Alabama at Birmingham, Birmingham, AL, USA. · Mellen Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA. · Department of Neurology, University at Buffalo, Buffalo, NY, USA. · Biogen, Cambridge, MA, USA. · National Multiple Sclerosis Society, New York, NY, USA. · Critical Path Institute, Tucson, AZ, USA. · Multiple Sclerosis Outcome Assessments Consortium (MSOAC), Critical Path Institute, Tucson, AZ, USA. · Pubmed 28206828
  • Department of Neurology and Buffalo General Medical Center, University at Buffalo, Buffalo, NY, USA. · Kessler Foundation, West Orange, NJ, USA; Rutgers New Jersey Medical School, Newark, NJ, USA. · Biogen, Cambridge, MA, USA. · National Multiple Sclerosis Society, New York, NY, USA. · Critical Path Institute, Tucson, AZ, USA. · Multiple Sclerosis Outcome Assessments Consortium (MSOAC), Critical Path Institute, Tucson, AZ, USA. · Pubmed 28206827
  • Rehabilitation Research Center (REVAL), Biomedical Research Institute (BIOMED), Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium. · Neuroscience Clinical Development, San Francisco, CA, USA. · Department of Neurology, University at Buffalo, Buffalo, NY, USA. · Biogen, Cambridge, MA, USA. · National Multiple Sclerosis Society, New York, NY, USA. · Critical Path Institute, Tucson, AZ, USA. · Multiple Sclerosis Outcome Assessments Consortium (MSOAC), Critical Path Institute, Tucson, AZ, USA. · Pubmed 28206826
  • Schey Center for Cognitive Neuroimaging, Lou Ruvo Center for Brain Health, Neurological Institute, Cleveland Clinic Foundation, Cleveland, OH, USA. · Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA. · Bayer Healthcare LLC, Whippany, NJ, USA. · McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC, Canada. · Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Cleveland, OH, USA. · Biogen, Cambridge, MA, USA. · Pubmed 28080262
2016
  • Biogen Inc., Cambridge, USA Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, USA · Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, USA. · Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, USA. · Biogen Inc., Cambridge, USA. · Pubmed 26238463
2015
  • Mellen Center for Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland, Ohio. · Biogen, Boston, Massachusetts. · Pubmed 26053218
Miscellaneous cities in USA
2015
  • Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, USA · Mellen Center for Multiple Sclerosis Treatment and Research/Neurological Institute Center for Outcomes Research and Evaluation/ Department of Quantitative Health Sciences, Cleveland Clinic, USA. · Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, USA. · Biogen Idec./Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, USA. · Pubmed 25112816
2014
2009
  • Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, USA. · Pubmed 19812410
Cleveland Clinic
2014
  • From the Department of Neurology (P.O.), St. Michael's Hospital, Toronto, Canada · Department of Neurology (A.G.), University of Rochester, NY · Departments of Neurology and Biomedicine (L.K.), University Hospital Basel, Switzerland · Corinne Goldsmith Dickinson Center for MS at The Icahn School of Medicine at Mount Sinai (F.L.), New York, NY · Department of Neurology (C.P.), VU Medical Centre, Amsterdam, the Netherlands · Mellen Center for Multiple Sclerosis Treatment and Research (R.A.R.), Cleveland Clinic Foundation, OH · Infusion Communications (K.H.), Haddam, CT · Departments of Safety and Benefit-Risk Management (L.M.C.) and Biostatistics (F.F.), Biogen Idec Inc., Cambridge · and Sarepta Therapeutics (P.D.), Cambridge, MA · P.D., a former employee of Biogen Idec Inc., was at the company during study conduct. · Pubmed 24898925
  • From the Corinne Goldsmith Dickenson Center for Multiple Sclerosis (F.D.L., A.E.M.), Icahn School of Medicine at Mount Sinai, New York, NY · Scientific and Clinical Review Associates, LLC (S.C.R.), Salisbury, CT · The Mellen Center for MS Treatment and Research (J.A.C., R.J.F., R.A.R.), Cleveland Clinic, OH · the Department of Biostatistics (G.R.C.), University of Alabama at Birmingham · the Danish Multiple Sclerosis Center (P.S.S.), Department of Neurology, Copenhagen University Hospital Rigshospitalet, Denmark · University College London Institute of Neurology (A.J.T.), UK · the Department of Neurology (J.S.W., J.A.L.), University of Texas Health Sciences Center, Houston · the Department of Neurology (L.J.B.), New York University Langone Medical Center, New York · the Division of Neurology (B. Banwell), The Children's Hospital of Philadelphia, PA · the Departments of Radiology and Nuclear Medicine (F.B.) and Neurology (C.H.P.), VU Medical Center, Amsterdam, the Netherlands · Research Programs Department (B. Bebo), National Multiple Sclerosis Society, New York, NY · the Department of Neurology (P.A.C.), The Johns Hopkins Hospital, Baltimore, MD · Fédération de Neurologie (M.C.), CHU Hôpital Purpan, Toulouse, France · the Department of Neurology (G.C.), Scientific Institute San Raffaele, University Vita-Salute San Raffaele, Milan, Italy · University of Ottawa and the Ottawa Hospital Research Institute (M.S.F.), Canada · the Department of Neurology (A.D.G.), University of Rochester Medical Center, NY · the Departments of Neurology, Radiology and Neuroscience (M.I.), Mount Sinai School of Medicine, New York, NY · the Department of Neurology (L.K.), University Hospital, Basel, Switzerland · the Department of Neurology (B.C.K.), Heinrich-Heine-University, Düsseldorf, Germany · the Department of Neurology (C.L.), Salpêtrière Hospital, UPMC, Paris, France · the Department of Neurology-Neuroimmunology (X.M.), Cemcat, Hospital Universitari Vall d'Hebron, Barcelona, Spain · the Division of · Pubmed 24871874
2013
  • Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. · Pubmed 23128399
2012
  • Mellen Center for Multiple Sclerosis Treatment and Research, Department of Neurology, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA. · Pubmed 22494954
2011
  • Mellen Center for Multiple Sclerosis Treatment and Research, Department of Neurology, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA. · Pubmed 21396360
  • Mellen Center for Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, United States of America. · Pubmed 21602934
  • Mellen Center for Multiple Sclerosis, Cleveland Clinic, 9500 Euclid Ave., U10, Cleveland, OH 44195, USA. · Pubmed 22123928
  • Mellen Center for Treatment and Research (Neurological Institute), The Cleveland Clinic Foundation, Cleveland, OH 44195, USA. · Pubmed 20965959
2010
  • Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, USA. · Pubmed 20625068
2009
  • Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, USA. · Pubmed 19446274
  • Mellen Center for Treatment and Research in Multiple Sclerosis, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA. · Pubmed 19506220
  • Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH 44106, USA. · Pubmed 19667023
  • Mellen Center for MS Treatment and Research U10, Neurologic Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA. · Pubmed 19100997
2008
  • Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. · Pubmed 18788835
  • Mellen Center for Multiple Sclerosis Treatment and Research, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA. · Pubmed 18774923
2015
  • 1Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA. · Pubmed 25271798
2013
  • Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research, 9500 Euclid Ave, Cleveland, OH 44195-5244, USA. · Pubmed 23599930
  • Neurological Institute, Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, OH, USA. · Pubmed 23378325
2012
  • Mellen Center, Department of Neurology, Cleveland Clinic, Cleveland, OH, USA. · Pubmed 23040960
2011
  • Department of Neurology, Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA. · Pubmed 21455068
  • Department of Molecular Genetics, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA. · Pubmed 22106296
  • Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, U-10 9500 Euclid Avenue, Cleveland, OH 44118, USA. · Pubmed 21300736
  • Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, Ohio 44195, USA. · Pubmed 21214498
2010
  • Mellen Center for Multiple Sclerosis Treatment and Research, U-10, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA. · Pubmed 20421570
  • Department of Neurology, Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH 44195, USA. · Pubmed 20167591
  • Mellen Center for Treatment and Research in Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA. · Pubmed 20064056
2009
  • Neuroinflammation Research Center, Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA. · Pubmed 20074275
2008
  • Department of Neurology, Mellen Center, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. · Pubmed 18701575
  • Department of Biomedical Engineering, Cleveland Clinic Foundation, Cleveland, OH 44195, USA. · Pubmed 18661561
Miscellaneous institutions in Cleveland
2014
  • From the Queen Mary University London (R.D., K.S., G.G.), Blizard Institute, UK · Neurological Institute (R.A.R.), Mellen Center for MS Treatment and Research, Cleveland, OH · and Royal London Hospital (R.D., B.T., K.S., G.G.), Barts Health NHS Trust, UK. · Pubmed 24336144
2013
  • Mellen Center for MS Treatment and Research, Cleveland, Ohio 44195, USA. · Pubmed 23818018
2012
  • Department of Neurology and Neurological Institute, ClevelandClinic, Cleveland, OH, USA. · Pubmed 22282644
Unspecified
2014
  • Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation; · Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation. · Center for Brain Health, Cleveland Clinic Foundation. · Quantitative Health Sciences, Cleveland Clinic Foundation. · Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic Foundation. · Pubmed 25046650
Miscellaneous cities in Massachusetts
2014
  • Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, Ohio. · Translational Neuroscience Facility, School of Medical Sciences, University of New South Wales, Sydney, Australia. · Department of Neurology, University of Rochester Medical Center, Rochester, New York. · Biogen Idec, Weston, Massachusetts. · Department of Neurology, Charles University, Prague, Czech Republic. · Department of Neurology, VU Medical Center, Amsterdam, the Netherlands. · Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, Ohio7currently with Biogen Idec, Weston, Massachusetts. · Pubmed 25178496
8 Other Locations Show
Yearly article counts 0513766111097
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.